Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
459.11M | 368.69M | 371.52M | 350.92M | 308.00M | 362.93M | Gross Profit |
158.21M | 92.99M | 87.34M | 86.97M | 48.11M | 70.18M | EBIT |
34.01M | 12.48M | 39.27M | 43.00M | 5.68M | 37.21M | EBITDA |
148.76M | 105.22M | 106.95M | 91.83M | 74.53M | 109.14M | Net Income Common Stockholders |
-15.24M | -5.29M | 23.01M | 25.54M | -4.60M | 18.59M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
6.06M | 6.06M | 11.14M | 13.62M | 15.92M | 20.09M | Total Assets |
439.96M | 439.96M | 469.37M | 464.47M | 444.39M | 508.05M | Total Debt |
193.24M | 193.24M | 204.03M | 201.86M | 194.71M | 251.75M | Net Debt |
187.18M | 187.18M | 192.89M | 188.25M | 178.79M | 231.66M | Total Liabilities |
286.94M | 286.94M | 294.44M | 297.88M | 291.27M | 338.12M | Stockholders Equity |
153.02M | 153.02M | 174.93M | 166.59M | 153.09M | 169.89M |
Cash Flow | Free Cash Flow | ||||
9.19M | 17.31M | 3.00M | 8.03M | 58.33M | 30.20M | Operating Cash Flow |
107.49M | 89.64M | 66.31M | 76.71M | 104.92M | 84.89M | Investing Cash Flow |
-95.35M | -47.06M | -38.46M | -53.55M | -29.05M | -36.63M | Financing Cash Flow |
-39.36M | -47.63M | -30.49M | -25.49M | -73.86M | -45.98M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | £57.44B | 16.90 | 16.07% | 1.73% | 1.78% | 15.53% | |
69 Neutral | £2.36B | 13.86 | 12.54% | 4.46% | -1.15% | -28.00% | |
68 Neutral | £851.25M | 11.85 | 8.62% | 13.11% | 0.82% | -26.44% | |
62 Neutral | $4.17B | 11.26 | 5.46% | 215.76% | 4.12% | -8.54% | |
62 Neutral | £97.22M | ― | -1.79% | 12.35% | -4.08% | 29.90% | |
49 Neutral | £197.31M | ― | -3.24% | 7.50% | -1.52% | -122.68% |